MYRON BRYANT: Open Payments
NPI 1437454550 · PINEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 19 payments from 7 companies in 2025. Trend: 2023 $615 · 2024 $240 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $244 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| ABBVIE INC. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: ARISTADA, LYBALVI, UZEDY, CAPLYTA, VRAYLAR, COBENFY, REXULTI, INGREZZA.
Industry payments across LA — which companies pay providers there.
